PCI Biotech Holding ASA
OSE:PCIB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
|
Curaleaf Holdings Inc
OTC:CURLF
|
CA |
|
B
|
Brookfield Asset Management Inc
XBER:BKAA
|
CA |
|
C
|
Cloudpoint Technology Bhd
KLSE:CLOUDPT
|
MY |
|
I
|
IMCD NV
SWB:INX
|
NL |
|
Gold Flora Corp
OTC:GRAM
|
US |
|
I
|
ideaForge Technology Ltd
NSE:IDEAFORGE
|
IN |
|
Bloomin' Brands Inc
NASDAQ:BLMN
|
US |
|
Econ Healthcare (Asia) Ltd
SGX:EHG
|
SG |
|
B
|
BCB Bhd
KLSE:BCB
|
MY |
|
Enzon Pharmaceuticals Inc
OTC:ENZN
|
US |
|
Toho Holdings Co Ltd
TSE:8129
|
JP |
|
Innovaderma PLC
LSE:IDP
|
UK |
|
British Land Company PLC
F:BLDA
|
UK |
|
Compass Minerals International Inc
NYSE:CMP
|
US |
|
B
|
Boston Properties Inc
F:BO9
|
US |
|
I
|
Isoenergy Ltd
SWB:I01
|
CA |
|
Restaurant Group PLC
LSE:RTN
|
UK |
|
B
|
Botnia Exploration Holding AB (publ)
STO:BOTX
|
SE |
|
I
|
Itama Ranoraya PT
IDX:IRRA
|
ID |
|
Liberty Defense Holdings Ltd
XTSX:SCAN
|
CA |
|
DCD Media PLC
LSE:DCD
|
UK |
|
Ibstock PLC
LSE:IBST
|
UK |
|
S
|
S & P Syndicate PCL
SET:SNP
|
TH |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PCIB's stock price target?
Not Available
PCIB does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for PCI Biotech Holding ASA?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been -1%. The projected CAGR for the next 3 years is 9%.